Raymond James analyst Steve Hansen downgrades Nutrien (NYSE:NTR) from Strong Buy to Outperform and raises the price target from $75 to $82.
The Market Can’t Make Up Its Mind, Neither Can The Federal Reserve: Why Fed Chair Jerome Powell Says Central Bank Remains Data Dependent
Fed Chair Jerome Powell came off dovish in a press conference following last week's decision on rates.